| Rapid whole-genome sequencing for investigation of a neonatal MRSA outbreak CU Köser*, MTG Holden*, MJ Ellington*, ... New England Journal of Medicine 366 (24), 2267-2275, 2012 | 748 | 2012 |
| Routine use of microbial whole genome sequencing in diagnostic and public health microbiology CU Köser, MJ Ellington, EJP Cartwright, SH Gillespie, NM Brown, ... PLoS Pathogens 8 (8), e1002824, 2012 | 606 | 2012 |
| The role of whole genome sequencing in antimicrobial susceptibility testing of bacteria: report from the EUCAST Subcommittee MJ Ellington, O Ekelund, FM Aarestrup, R Canton, M Doumith, C Giske, ... Clinical Microbiology and Infection 23 (1), 2-22, 2017 | 441 | 2017 |
| A standardised method for interpreting the association between mutations and phenotypic drug resistance in Mycobacterium tuberculosis P Miotto, B Tessema, E Tagliani, L Chindelevitch, AM Starks, C Emerson, ... European Respiratory Journal 50 (6), 2017 | 332 | 2017 |
| Whole-genome sequencing to control antimicrobial resistance CU Köser, MJ Ellington, SJ Peacock Trends in Genetics 30 (9), 401-407, 2014 | 279 | 2014 |
| Whole-genome sequencing for rapid susceptibility testing of M. tuberculosis CU Köser, JM Bryant, J Becq, ME Török, MJ Ellington, MA Marti-Renom, ... New England Journal of Medicine 369 (3), 290-292, 2013 | 254 | 2013 |
| Rapid bacterial whole-genome sequencing to enhance diagnostic and public health microbiology S Reuter, MJ Ellington, EJP Cartwright, CU Köser, ME Török, T Gouliouris, ... JAMA Internal Medicine 173 (15), 1397-1404, 2013 | 220 | 2013 |
| Technical report on critical concentrations for drug susceptibility testing of medicines used in the treatment of drug-resistant tuberculosis World Health Organization World Health Organization, 2018 | 209 | 2018 |
| Mycobacterium tuberculosis drug-resistance testing: challenges, recent developments and perspectives T Schön, P Miotto, CU Köser, M Viveiros, E Böttger, E Cambau Clinical Microbiology and Infection 23 (3), 154-160, 2017 | 185 | 2017 |
| Genomic diversity among drug sensitive and multidrug resistant isolates of Mycobacterium tuberculosis with identical DNA fingerprints S Niemann*, CU Köser* (*equal contributions), S Gagneux, C Plinke, ... PLoS One 4 (10), e7407, 2009 | 184 | 2009 |
| A pilot study of rapid whole-genome sequencing for the investigation of a Legionella outbreak S Reuter, TG Harrison, CU Köser, MJ Ellington, GP Smith, J Parkhill, ... BMJ Open 3 (1), e002175, 2013 | 125 | 2013 |
| What Is resistance? Impact of phenotypic versus molecular drug resistance testing on therapy for multi- and extensively drug-resistant tuberculosis J Heyckendorf, S Andres, CU Köser, ID Olaru, T Schön, E Sturegård, ... Antimicrobial Agents and Chemotherapy 62 (2), e01550-17, 2018 | 108 | 2018 |
| Genome sequencing defines phylogeny and spread of methicillin-resistant Staphylococcus aureus in a high transmission setting SYC Tong, MTG Holden, EK Nickerson, BS Cooper, CU Köser, A Cori, ... Genome Research 25 (1), 111-118, 2015 | 108 | 2015 |
| Systematic review of mutations associated with resistance to the new and repurposed Mycobacterium tuberculosis drugs bedaquiline, clofazimine, linezolid … S Kadura, N King, M Nakhoul, H Zhu, G Theron, CU Köser, M Farhat Journal of Antimicrobial Chemotherapy 75 (8), 2031-2043, 2020 | 102 | 2020 |
| Mycobacterium tuberculosis resistance prediction and lineage classification from genome sequencing: comparison of automated analysis tools. V Schleusener, CU Köser, P Beckert, S Niemann, S Feuerriegel Scientific Reports 7, 46327, 2017 | 98 | 2017 |
| Phylogenetic polymorphisms in antibiotic resistance genes of the Mycobacterium tuberculosis complex S Feuerriegel, CU Köser, S Niemann Journal of Antimicrobial Chemotherapy 69 (5), 1205-1210, 2014 | 97 | 2014 |
| Rapid whole-genome sequencing for investigation of a suspected tuberculosis outbreak ME Török, S Reuter, J Bryant, CU Köser, SV Stinchcombe, B Nazareth, ... Journal of Clinical Microbiology 51 (2), 611-614, 2013 | 82 | 2013 |
| Importance of the genetic diversity within the Mycobacterium tuberculosis complex for the development of novel antibiotics and diagnostic tests of drug resistance CU Köser, S Feuerriegel, DK Summers, JAC Archer, S Niemann Antimicrobial Agents and Chemotherapy 56 (12), 6080-6087, 2012 | 80 | 2012 |
| Prevalence and genetic profiles of isoniazid resistance in tuberculosis patients: A multicountry analysis of cross-sectional data AS Dean, M Zignol, AM Cabibbe, D Falzon, P Glaziou, DM Cirillo, ... PLOS Medicine 17 (1), e1003008, 2020 | 76 | 2020 |
| Impact of fgd1 and ddn diversity in Mycobacterium tuberculosis complex on in vitro susceptibility to PA-824 S Feuerriegel*, CU Köser* (*equal contributions), D Baù, S Rüsch-Gerdes, ... Antimicrobial Agents and Chemotherapy 55 (12), 5718-5722, 2011 | 76 | 2011 |
